Pharmafile Logo

AMRI Global

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. The company provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

Mostyn Road, Holywell, Flintshire, Wales, CH8 9DN, United Kingdom
+44 (0)1352 717100

 Latest Content from PMHub 

Virtual Steering Committee & Peer Influence Program

In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program.

SCIRIS ACQUIRES SOURCE HEALTH ECONOMICS

Global healthcare communications company SCIRIS is delighted to announce the acquisition of UK-based Source Health Economics – an agency specialising in health economics and outcomes research (HEOR).The development is the...

How to Increase Engagement During Virtual Events

Tip #8 - Do you make sure to have a host for all your virtual events? Check our top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/

Report gives insights to address gaps in HCP engagement

How does Pharma-HCP engagement need to evolve in today's digital landscape?

Cuttsy+Cuttsy campaign takes health literacy to the North Pole

Our 2022 Christmas campaign saw Santa’s agency elves creating tailored materials for patients. But were the examples guided by the principles of health literacy? Were they naughty or nice?

World-renowned creative icon Jeremy Perrott joins KVA

Press Releases | January 16, 2023 | KVA

KVA are excited to announce that Jeremy Perrott is joining the digital comms healthcare agency as a Board Advisor

Video: Strategic engagement case study

White Papers and Resources | January 13, 2023 | Inizio

Supporting the launch of a global vaccine with a programme of market research and strategic insights

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

White Papers and Resources | January 13, 2023 | Inizio

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

Repurposing Off-Patent Drugs Through Crowd Funding

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. 

The impact of mindset on digital product success: Download our new whitepaper

Press Releases | January 11, 2023 | Graphite Digital

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...